FDA Inspection 937014 — Actelion Pharmaceuticals Ltd.

Actelion Pharmaceuticals Ltd. — FEI 3002995923

The FDA completed an inspection of Actelion Pharmaceuticals Ltd. on July 16, 2015 in Allschwil. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 16, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allschwil (Switzerland)